Victory Capital Management Inc. trimmed its holdings in Aetna Inc. (NYSE:AET) by 7.5% during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 484,477 shares of the company’s stock after selling 39,489 shares during the period. Victory Capital Management Inc. owned about 0.15% of Aetna worth $77,036,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors have also made changes to their positions in the company. Bruderman Asset Management LLC purchased a new stake in shares of Aetna in the second quarter worth about $106,000. Liberty Capital Management Inc. increased its stake in Aetna by 206.9% during the second quarter. Liberty Capital Management Inc. now owns 933 shares of the company’s stock worth $144,000 after acquiring an additional 629 shares during the last quarter. Westside Investment Management Inc. increased its stake in Aetna by 53.5% during the second quarter. Westside Investment Management Inc. now owns 1,148 shares of the company’s stock worth $177,000 after acquiring an additional 400 shares during the last quarter. Phocas Financial Corp. bought a new stake in Aetna during the second quarter worth approximately $182,000. Finally, Highstreet Asset Management Inc. grew its stake in shares of Aetna by 105.5% during the third quarter. Highstreet Asset Management Inc. now owns 1,243 shares of the company’s stock valued at $198,000 after buying an additional 638 shares during the last quarter. Institutional investors and hedge funds own 91.06% of the company’s stock.
ILLEGAL ACTIVITY WARNING: This news story was originally reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this news story on another domain, it was stolen and republished in violation of United States and international copyright & trademark laws. The correct version of this news story can be viewed at https://www.dispatchtribunal.com/2017/11/12/victory-capital-management-inc-has-77-04-million-stake-in-aetna-inc-aet.html.
Aetna Inc. (NYSE AET) traded up $2.59 during trading on Friday, hitting $175.12. 2,240,900 shares of the stock traded hands, compared to its average volume of 3,100,742. Aetna Inc. has a 1-year low of $116.04 and a 1-year high of $184.98. The stock has a market cap of $57,106.63, a PE ratio of 17.15, a P/E/G ratio of 1.60 and a beta of 0.61. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 0.52.
Aetna (NYSE:AET) last announced its earnings results on Tuesday, October 31st. The company reported $2.45 EPS for the quarter, beating analysts’ consensus estimates of $2.06 by $0.39. Aetna had a net margin of 2.93% and a return on equity of 21.84%. The business had revenue of $14.99 billion during the quarter, compared to analysts’ expectations of $15.12 billion. During the same period in the prior year, the company earned $2.07 earnings per share. The business’s revenue was down 5.0% compared to the same quarter last year. sell-side analysts expect that Aetna Inc. will post 9.78 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Thursday, October 12th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.14%. The ex-dividend date was Wednesday, October 11th. Aetna’s dividend payout ratio is currently 37.04%.
A number of research analysts have recently commented on the company. Piper Jaffray Companies reaffirmed a “hold” rating and set a $187.00 target price on shares of Aetna in a research note on Friday, November 3rd. Raymond James Financial, Inc. upgraded Aetna from a “market perform” rating to an “outperform” rating and set a $200.00 price target for the company in a report on Friday, November 3rd. Credit Suisse Group assumed coverage on Aetna in a report on Thursday, November 2nd. They set a “neutral” rating and a $174.00 target price for the company. Zacks Investment Research lowered Aetna from a “buy” rating to a “hold” rating in a report on Thursday, November 2nd. Finally, Citigroup Inc. upped their target price on Aetna from $183.00 to $197.00 and gave the stock a “buy” rating in a report on Thursday, November 2nd. Eleven investment analysts have rated the stock with a hold rating and fourteen have given a buy rating to the company’s stock. Aetna presently has a consensus rating of “Buy” and an average target price of $170.34.
In other Aetna news, EVP Margaret M. Mccarthy sold 10,288 shares of the firm’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $162.85, for a total transaction of $1,675,400.80. Following the completion of the transaction, the executive vice president now directly owns 33,563 shares of the company’s stock, valued at approximately $5,465,734.55. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, President Karen S. Lynch sold 15,271 shares of the firm’s stock in a transaction on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the transaction, the president now directly owns 64,261 shares of the company’s stock, valued at $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.